Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GSPT1 inhibitors(G1 to S phase transition 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Cyrus Therapeutics, Inc.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | KR | 04 Jan 2024 | |
Hematologic Neoplasms | Preclinical | KR | Cyrus Therapeutics, Inc.Startup | 04 Jan 2024 |
Solid tumor | Preclinical | KR | Cyrus Therapeutics, Inc.Startup | 04 Jan 2024 |
Solid tumor | Preclinical | KR | 04 Jan 2024 |